Original Article

You have full text access to this OnlineOpen article

Presence of the latent membrane protein 1 gene in nasopharyngeal swabs from patients with mucosal recurrent nasopharyngeal carcinoma

  1. Ngan-Ming Tsang D.Sc.1,
  2. Chi-Cheng Chuang M.D.2,
  3. Chen-Kan Tseng M.D.1,
  4. Sheng-Po Hao M.D.3,
  5. Tseng-Tong Kuo M.D., Ph.D.4,
  6. Chien-Yu Lin M.D.1,
  7. Ping-Ching Pai M.D.1,†,*

Article first published online: 7 OCT 2003

DOI: 10.1002/cncr.11820

Issue

Cancer

Cancer

Volume 98, Issue 11, pages 2385–2392, 1 December 2003

Additional Information

How to Cite

Tsang, N.-M., Chuang, C.-C., Tseng, C.-K., Hao, S.-P., Kuo, T.-T., Lin, C.-Y. and Pai, P.-C. (2003), Presence of the latent membrane protein 1 gene in nasopharyngeal swabs from patients with mucosal recurrent nasopharyngeal carcinoma. Cancer, 98: 2385–2392. doi: 10.1002/cncr.11820

Author Information

  1. 1

    Department of Radiation Oncology, Chang Gung Memorial Hospital, Linkou, Taiwan, Republic of China

  2. 2

    Department of Neurosurgery, Chang Gung Memorial Hospital, Linkou, Taiwan, Republic of China

  3. 3

    Department of Otolaryngology, Chang Gung Memorial Hospital, Linkou, Taiwan, Republic of China

  4. 4

    Department of Pathology, Chang Gung Memorial Hospital, Linkou, Taiwan, Republic of China

  1. †

    Fax: (011) 886 33280797

*Department of Radiation Oncology, Chang Gung Memorial Hospital, 5 Fu-Shin Street, Kwei-Shan Hsiang, Taoyuan, Taiwan, Republic of China

Publication History

  1. Issue published online: 17 NOV 2003
  2. Article first published online: 7 OCT 2003
  3. Manuscript Accepted: 1 SEP 2003
  4. Manuscript Revised: 20 AUG 2003
  5. Manuscript Received: 10 JUN 2003

Funded by

  • National Science Council of Taiwan. Grant Number: NMRPG1163
  • Chang Gung University. Grant Number: CMRP 1041
  • Chang Gung Memorial Hospital Cancer Center–Terry Fox Foundation. Grant Number: SMRPG1011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (119K)

REFERENCES

  • 1
    Lee AW, Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992; 23: 261–270.
  • 2
    Mesic JB, Fletcher GH, Goepfert H. Megavoltage irradiation of epithelial tumors of the nasopharynx. Int J Radiat Oncol Biol Phys. 1981; 7: 447–453.
  • 3
    Zhang EP, Lian PG, Cai KL, et al. Radiation therapy of nasopharyngeal carcinoma: Prognostic factors based on a 10-year follow-up of 1302 patients. Int J Radiat Oncol Biol Phys. 1989; 16: 301–305.
  • 4
    Orecchia R, Redda MG, Ragona R, et al. Results of hypofractionated stereotactic re-irradiation on 13 locally recurrent nasopharyngeal carcinomas. Radiother Oncol. 1999; 53: 23–28.
  • 5
    Wang CC. Re-irradiation of recurrent nasopharyngeal carcinoma—treatment techniques and results. Int J Radiat Oncol Biol Phys. 1987; 13: 953–956.
  • 6
    Hsu MM, Ko JY, Sheen TS, Chang YL. Salvage surgery for recurrent nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 1997; 123: 305–309.
  • 7
    Law SC, Lam WK, Ng MF, Au SK, Mak WT, Lau WH. Reirradiation of nasopharyngeal carcinoma with intracavitary mold brachytherapy: an effective means of local salvage. Int J Radiat Oncol Biol Phys. 2002; 54: 1095–1113.
  • 8
    Pai PC, Chuang CC, Wei KC, Tsang NM, Tseng CK, Chang CN. Stereotactic radiosurgery for locally recurrent nasopharyngeal carcinoma. Head Neck. 2002; 24: 748–753.
    Direct Link:
  • 9
    Hsiung CY, Yorke ED, Chui CS, et al. Intensity-modulated radiotherapy versus conventional three-dimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2002; 53: 638–647.
  • 10
    Moghaddam A, Rosenzweig M, Lee-Parritz D, Annis B, Johnson RP, Wang F. An animal model for acute and persistent Epstein–Barr virus infection. Science. 1997; 276: 2030–2033.
  • 11
    Niedobitek G, Young LS. Epstein–Barr virus persistence and virus-associated tumours. Lancet. 1994; 343: 333–335.
  • 12
    Pearson GR, Weiland LH, Neel HB III, et al. Application of Epstein–Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma. Otolaryngol Head Neck Surg. 1983; 51: 260–268.
  • 13
    Zong YS, Sham JS, Ng MH, et al. Immunoglobulin A against viral capsid antigen of Epstein–Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma. Cancer. 1992; 69: 3–7.
    Direct Link:
  • 14
    Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell. 1985; 43: 831–840.
  • 15
    Dawson CW, Rickinson AB, Young LS. Epstein–Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature. 1990; 344: 777–780.
  • 16
    Young LS, Dawson CW, Clark D, et al. Epstein–Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol. 1988; 69: 1051–1065.
  • 17
    Cooper JS, Cohen R, Stevens RE. A comparison of staging systems for nasopharyngeal carcinoma. Cancer. 1998; 83: 213–219.
    Direct Link:
  • 18
    Lin SY, Tsang NM, Kao SC, et al. Presence of Epstein–Barr virus latent membrane protein 1 gene in the nasopharyngeal swabs from patients with nasopharyngeal carcinoma. Head Neck. 2000; 23: 194–200.
    Direct Link:
  • 19
    Gulley ML, Raab-Traub N. Detection of Epstein–Barr virus in human tissues by molecular genetic techniques. Arch Pathol Lab Med. 1993; 117: 1115–1120.
  • 20
    Sheen TS, Ko JY, Chang YL, et al. Nasopharyngeal swab and PCR for the screening of nasopharyngeal carcinoma in the endemic area: a good supplement to the serologic screening. Head Neck. 1998; 20: 732–738.
    Direct Link:
  • 21
    Wei WI, Sham JS, Zong YS. The efficacy of fiberoptic endoscopic examination and biopsy in the detection of early nasopharyngeal carcinoma. Cancer. 1991; 67: 3127–3130.
    Direct Link:
  • 22
    Chong VF, Fan YF. Detection of recurrent nasopharyngeal carcinoma: MR imaging versus CT. Radiology. 1997; 202: 463–470.
  • 23
    Olmi P, Fallai C, Colagrande S, Giannardi G. Staging and follow-up of nasopharyngeal carcinoma: magnetic resonance imaging versus computerized tomography. Int J Radiat Oncol Biol Phys. 1995; 32: 795–800.
  • 24
    Tsai MH, Shiau YC, Kao CH, Shen YY, Lin CC, Lee CC. Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy. J Cancer Res Clin Oncol. 2002; 128: 279–282.
  • 25
    Tune CE, Liavaag PG, Freeman JL, et al. Nasopharyngeal brush biopsies and detection of nasopharyngeal Cancer in a high-risk population. J Natl Cancer Inst. 1999; 91: 796–800.
  • 26
    Hoo SP, Tsang NM, Chong KP. Screening nasopharyngeal carcinoma by detection of the latent membrane protein 1 (LMP-1) gene with nasopharyngeal swabs. Cancer. 2003; 97: 1909–1913.
    Direct Link:
  • 27
    Zhang XS, Song KH, Mai HQ, et al. The 30-bp deletion variant: a polymorphism of latent membrane protein 1 prevalent in endemic and non-endemic areas of nasopharyngeal carcinomas in China. Cancer Lett. 2002; 176: 65–73.
View Full Article (HTML) Get PDF (119K)